Page last updated: 2024-11-05

dimethyl methylphosphonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID12958
CHEMBL ID2924224
SCHEMBL ID35767
SCHEMBL ID11333660
MeSH IDM0097992

Synonyms (74)

Synonym
unii-20z996230u
ec 212-052-3
phosphonic acid, p-methyl-, dimethyl ester
20z996230u ,
4-04-00-03499 (beilstein handbook reference)
dimethoxymethylphosphine oxide
nsc62240
methanephosphonic acid, dimethyl ester
wln: 1opo&1&o1
nci-c54762
pyrol dmmp
dimethyl methanephosphonate
nsc-62240
dmmp
756-79-6
inchi=1/c3h9o3p/c1-5-7(3,4)6-2/h1-3h
phosphonic acid, methyl-, dimethyl ester
dimethyl methylphosphonate
einecs 212-052-3
hsdb 2590
ccris 876
c3h9o3p
ai3-08678
phosphonic acid, methyl-,dimethyl ester
fyrol dmmp
methyl phosphonic acid, dimethyl ester
dimethylmethylphosphonate
nsc 62240
brn 0878263
methylphosphonic acid dimethyl ester
methanephosphonic acid dimethyl ester
GHL.PD_MITSCHER_LEG0.664
dimethyl methylphosphonate, 97%
NCIOPEN2_003730
[methoxy(methyl)phosphoryl]oxymethane
M0943
A838480
NCGC00249063-01
(methoxy-methylphosphoryl)oxymethane
tox21_303029
dtxsid0020494 ,
NCGC00256579-01
dtxcid40494
cas-756-79-6
tox21_201534
NCGC00259084-01
FT-0628285
AKOS015913384
CHEMBL2924224
dmmp [mi]
dimethyl methylphosphonate [hsdb]
p-methylphosphonic acid dimethyl ester
SCHEMBL35767
reoflam dmmp
dimethyl methyl-phosphonate
dimethyl methylphosphonoate
methyl-phosphonic-acid dimethyl ester
h3c-po(och3)2
mep(o)(ome)2
methane phosphonic acid dimethylester
methyl-phosphonic acid dimethyl ester
methane phosphonic acid dimethyl ester
SCHEMBL11333660
furan tf 2000
dimethyl ester of methylphosphonic acid
dimethoxymethyl phosphine oxide
metaran
o,o-dimethyl methylphosphonate
dimethyl methyl phosphonate
mfcd00008349
dimethyl methylphosphonate, purum, >=97.0% (gc)
CS-0040741
Q417529
dimethyl methane phosphonate

Research Excerpts

Overview

Dimethyl methylphosphonate (DMMP) is a widely used chemical. It impairs fertility in male rodents.

ExcerptReferenceRelevance
"Dimethyl methylphosphonate (DMMP) is an organophosphorous compound that impairs fertility in male rodents. "( Development of reproductive tract lesions in male F344 rats after treatment with dimethyl methylphosphonate.
Chapin, RE; Dutton, SL; Lamb, JC; Ross, MD; Sumrell, BM, 1984
)
1.94
"Dimethyl methylphosphonate (DMMP) is a widely used chemical. "( Biotransformation and male rat-specific renal toxicity of diethyl ethyl- and dimethyl methylphosphonate.
Blumbach, K; Deger, HM; Dekant, W; Pähler, A, 2000
)
1.98

Toxicity

ExcerptReferenceRelevance
" Also, glycerol at high osmolality was not toxic and did not induce aberrations, probably because rapid equilibration across the cell membrane precluded severe osmotic stress to the cells."( Effects of high osmotic strength on chromosome aberrations, sister-chromatid exchanges and DNA strand breaks, and the relation to toxicity.
Armstrong, MJ; Bean, CL; Bradley, MO; Deasy, DA; Galloway, SM; Kraynak, AR, 1987
)
0.27

Dosage Studied

ExcerptRelevanceReference
" Survival in dosed male rats was reduced, due in part to kidney toxicity, and lesions in the kidney included increased severity of spontaneous nephropathy, calcification, hyperplasia of the tubular and transitional epithelium, tubular cell adenocarcinomas, and transitional cell papillomas and carcinomas."( Development of kidney tumors in the male F344/N rat after treatment with dimethyl methylphosphonate.
Dunnick, JK; Eustis, SL; Haseman, JK, 1988
)
0.51
" DMMP was administered to male Fischer 344 rats by gavage 5 days/week for 90 days at dosages of 0, 250, 500, 1000, and 2000 mg/kg, and all animals survived this dosing schedule."( Reproductive toxicity of dimethyl methyl phosphonate (DMMP) in the male Fischer 344 rat.
Dunnick, JK; Gupta, BN; Harris, MW; Lamb, JC, 1984
)
0.27
" Relative kidney weights were increased in male rats dosed with DMMP, DEEP, and TMP."( Biotransformation and male rat-specific renal toxicity of diethyl ethyl- and dimethyl methylphosphonate.
Blumbach, K; Deger, HM; Dekant, W; Pähler, A, 2000
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.30120.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency25.82120.001530.607315,848.9004AID1224841; AID1224842
estrogen nuclear receptor alphaHomo sapiens (human)Potency12.69510.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1880635Tanol-water partition coefficient, logP of compound by shake flask method based 31P-NMR analysis2022Journal of medicinal chemistry, 06-23, Volume: 65, Issue:12
Studying Lipophilicity Trends of Phosphorus Compounds by
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (96)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (9.38)18.7374
1990's12 (12.50)18.2507
2000's31 (32.29)29.6817
2010's36 (37.50)24.3611
2020's8 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.08 (24.57)
Research Supply Index4.58 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index66.94 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.03%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other96 (98.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]